Key facts
- Adona Medical’s last known valuation is $165.0M.
- It has raised $95.5M across 3 recorded rounds; the latest was Early Stage VC ($13.4M) in Jun 2024.
- Notable investors include Correlation Ventures, Cormorant Asset Management, TCP Health Ventures, AMED Ventures, Excelestar Ventures — 9 tracked in total.
- Adona Medical has filed 3 Form Ds with the SEC since 2020, most recently Jul 2024 ($13.4M sold to 23 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Adona Medical
Funding rounds
3 roundsAbout Adona Medical
Developer of a heart failure management system designed for personalized, tailored management of cardiac patients. The company's system enhances the standard of heart care through sensor and shunt technologies, enabling physicians to address each patient's needs with interatrial shunt technology, providing a proper understanding of a patient's hemodynamic status.
- Sector
- Healthcare
- HQ
- Los Gatos, CA, United States
- Founded
- 2017
- Employees
- 48
- Website
- adonamed.com/
- Ownership
- Privately Held (backing)
Adona Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Adona Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Adona Medical in its N-PORT filings yet. We sweep new filings monthly.